Merck
  • QBD10243
All Photos(1)

QBD10243

Sigma-Aldrich

Fmoc-N-amido-dPEG®2-acid

>95% (HPLC)

Synonym(s):
Fmoc-N-amido-PEG2-COOH, Fmoc-N-amido-PEG2-acid, Fmoc-PEG-acid, Fmoc-PEG2-acid
Empirical Formula (Hill Notation):
C22H25NO6
Molecular Weight:
399.44
MDL number:

Assay

>95% (HPLC)

form

solid or viscous liquid

reaction suitability

reaction type: Pegylations

polymer architecture

shape: linear
functionality: homobifunctional

shipped in

ambient

storage temp.

−20°C

Compare Similar Items

View Full Comparison

1 of 4

This Item
QBD10313QBD10273QBD10903
assay

>95% (HPLC)

assay

>90%

assay

>95% (HPLC)

assay

>95% (HPLC)

form

solid or viscous liquid

form

solid or viscous liquid

form

solid or viscous liquid

form

solid or viscous liquid

reaction suitability

reaction type: Pegylations

reaction suitability

reaction type: Pegylations, reagent type: cross-linking reagent

reaction suitability

reaction type: Pegylations

reaction suitability

reaction type: Pegylations

polymer architecture

shape: linear
functionality: homobifunctional

polymer architecture

shape: linear
functionality: heterobifunctional

polymer architecture

shape: linear
functionality: heterobifunctional

polymer architecture

shape: linear
functionality: heterobifunctional

shipped in

ambient

shipped in

ambient

shipped in

ambient

shipped in

ambient

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

Features and Benefits

Fmoc-N-amido-dPEG2-acid is a monodisperse PEG product that is useful for peptide synthesis. The ten-atom dPEG spacer allows the introduction of a short, hydrophilic spacer onto either end of a peptide chain or between two peptide chains. The flexible dPEG spacer conjugates to peptides using conventional peptide synthesis chemistry. Peptide PEGylation imparts water solubility to hydrophobic peptide chains. Also, PEGylated peptides have expanded hydrodynamic volumes, which can reduce or eliminate renal clearance, and are protected from proteolysis. The combination of decreased renal clearance and protection from proteolysis contributes to longer in vivo circulation times for PEGylated (as compared to non-PEGylated) peptides. Additionally, PEGylation diminishes a peptide′s antigenicity. This product is part of the Fmoc-N-amido-dPEGn-acid (n=2, 3, 4, 5, 6, 8, 12, 24, 36) product series.

Legal Information

Products Protected under U.S. Patent #s 7,888,536 & 8,637,711 and European Patent #s 1,594,440 & 2,750,681
dPEG is a registered trademark of Quanta BioDesign

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

More Documents

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service